Moderna’s COVID-19 Vaccine Spikevax Receives Full FDA Approval for Children Aged 6 Months to 11 Years at “Increased Risk” Despite Mounting Safety Concerns and Public Distrust
The U.S. Food and Drug Administration (FDA) has officially granted full approval to Moderna’s controversial mRNA COVID-19 vaccine, Spikevax, for children as